Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005017
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2000-04-03
Brief Title:
Effectiveness and Safety of EpivirZiagenZerit 3TCABCd4T Versus EpivirZiagenSustiva 3TCABCEFV Versus EpivirZiagenAgeneraseNorvir 3TCABCAPVRTV in HIV Patients Who Have Never Received Treatment
Sponsor:
Organization:
NIH AIDS Clinical Trials Information Service
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
300
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: